fda glp-1 news november 2025 compounding semaglutide enforcement The FDA has released new guidance for providers prescribing GLP-1 Shortage = Over How FDA Crackdowns Are Affecting

These are big numbers, and if youre one of the 3 million looking to start on one of these medications soon, its vital you understand exactly how theyre working

Similar reductions were observed among patients with lupus nephritis specifically

FDA should absolutely reject bad actors who mislead patients or blur regulatory lines

A quick reference to help you better understand your prescribed treatment

Many patients find that meal satisfaction improves within 4-6 weeks as taste perception normalizes, so temporary dietary adjustments often transition back to broader food variety

Leptin signaling in human peripheral blood mononuclear cells, activation of p38 and p42/44 mitogen-activated protein (MAP) kinase and p70 S6 kinase